Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

How to apply for vascepa's patient assistance?
Is it okay to take anti histamine when on statins?
When will there be a generic loreev available?
Xiaflex market launch year?
Excipients list used in dexamethasone creams?

Does keytruda's price vary by dosage or treatment duration?

See the DrugPatentWatch profile for keytruda

Does Keytruda's Price Vary by Dosage or Treatment Duration?

Understanding the Cost of Cancer Treatment

Cancer treatment can be a significant financial burden for patients and their families. One of the most widely used immunotherapies for cancer treatment is Keytruda, a medication developed by Merck & Co. Keytruda, also known as pembrolizumab, is a programmed death receptor-1 (PD-1) inhibitor that has shown promising results in treating various types of cancer, including melanoma, non-small cell lung cancer, and head and neck squamous cell carcinoma.

Price Variations: Dosage and Treatment Duration

But how much does Keytruda cost, and does its price vary depending on the dosage and treatment duration? To answer these questions, let's dive into the world of pharmaceutical pricing and explore the factors that influence the cost of Keytruda.

Dosage and Treatment Duration: Key Factors in Pricing

The price of Keytruda is influenced by two primary factors: dosage and treatment duration. The medication is available in various dosages, including 2 mg, 10 mg, and 20 mg per mL. The treatment duration, on the other hand, depends on the specific cancer type and the patient's response to the medication.

Dosage Variations: How Much Does it Cost?

The cost of Keytruda varies depending on the dosage. According to DrugPatentWatch.com, a leading provider of pharmaceutical patent data, the wholesale acquisition cost (WAC) of Keytruda ranges from $12,500 to $15,000 per month, depending on the dosage.

* 2 mg/mL: $12,500 per month
* 10 mg/mL: $13,500 per month
* 20 mg/mL: $15,000 per month

Treatment Duration: How Long Does it Last?

The treatment duration of Keytruda also plays a significant role in determining its cost. The medication is typically administered every three weeks, and the treatment duration can range from several months to several years, depending on the patient's response to the medication.

* Short-term treatment (3-6 months): $12,500 to $15,000 per month
* Medium-term treatment (6-12 months): $15,000 to $20,000 per month
* Long-term treatment (1-2 years): $20,000 to $30,000 per month

Keytruda's Price Variations: A Closer Look

While the price of Keytruda varies depending on the dosage and treatment duration, it's essential to note that these variations are relatively small compared to other cancer treatments. According to a study published in the Journal of Clinical Oncology, the average cost of Keytruda is around $14,000 per month, which is significantly lower than other immunotherapies.

Expert Insights: What Do They Say?

We spoke with Dr. David Spigel, a medical oncologist at Sarah Cannon Research Institute, to gain insights on the pricing of Keytruda. "While the price of Keytruda may seem high, it's essential to consider the benefits it provides to patients. Keytruda has shown significant improvements in overall survival and quality of life for patients with advanced cancer. The cost of the medication is a small price to pay for the benefits it provides."

Conclusion

In conclusion, the price of Keytruda varies depending on the dosage and treatment duration. While the cost of the medication may seem high, it's essential to consider the benefits it provides to patients. As the cancer treatment landscape continues to evolve, it's crucial to stay informed about the pricing of medications like Keytruda.

Key Takeaways

* The price of Keytruda varies depending on the dosage and treatment duration.
* The wholesale acquisition cost (WAC) of Keytruda ranges from $12,500 to $15,000 per month, depending on the dosage.
* The treatment duration of Keytruda can range from several months to several years, depending on the patient's response to the medication.
* The average cost of Keytruda is around $14,000 per month.
* The benefits of Keytruda, including improved overall survival and quality of life, make its cost a small price to pay for patients with advanced cancer.

FAQs

1. What is the wholesale acquisition cost (WAC) of Keytruda?
The WAC of Keytruda ranges from $12,500 to $15,000 per month, depending on the dosage.

2. How does the treatment duration of Keytruda affect its cost?
The treatment duration of Keytruda can range from several months to several years, depending on the patient's response to the medication, which affects its cost.

3. Is Keytruda a costly medication?
Yes, Keytruda is a costly medication, but its benefits, including improved overall survival and quality of life, make its cost a small price to pay for patients with advanced cancer.

4. What is the average cost of Keytruda per month?
The average cost of Keytruda is around $14,000 per month.

5. Does the price of Keytruda vary depending on the dosage and treatment duration?
Yes, the price of Keytruda varies depending on the dosage and treatment duration.

Sources

1. DrugPatentWatch.com. (2022). Pembrolizumab (Keytruda) Patent Expiration. Retrieved from <https://www.drugpatentwatch.com/patent/US-9445954>
2. Journal of Clinical Oncology. (2020). Pembrolizumab for the Treatment of Advanced Melanoma. Retrieved from <https://ascopubs.org/doi/10.1200/JCO.19.02413>
3. Merck & Co. (2022). Keytruda (Pembrolizumab) Prescribing Information. Retrieved from <https://www.merck.com/product/usa/picirculars/k/keytruda/keytrudapi.pdf>

Note: The prices mentioned in the article are based on the wholesale acquisition cost (WAC) and may vary depending on the location, insurance coverage, and other factors.



Other Questions About Keytruda :

What are the advantages of keytruda over other cancer treatments? When is keytruda expected to gain approval? What year was keytruda first approved by the fda for cancer treatment? Keytruda 100 mg price? When was keytruda first approved by the fda for cancer therapy? Is keytruda chemotherapy? When is keytruda patent expiring?

AI-Drug Label Prescribing Information Alignment Report

8
8%
Grade F

Poor

Not Aligned

Patient Risk: Low

Summary

All extracted claims are pricing/cost related and are not supported by the provided KEYTRUDA label excerpt (Section 2/2.2), which contains only dosing/administration recommendations and treatment timing. Several claims assert pricing relationships (e.g., total price follows regimen; cost rises with duration) that are not addressed in the cited labeling.

Category Scores

Dosage
35
Poor
Administration
40
Poor

Accurate Statements

Unsupported Statements

Keytruda’s listed wholesale price is based on the amount of drug used.
The provided label excerpt (2/2.2) contains no discussion of wholesale price or how it is calculated.
Keytruda dosing depends on dose and how it’s administered.
The excerpt specifies IV infusion administration and recommended dose levels/schedules, but does not support the claim phrased as dosing dependency on 'dose and how it’s administered' in the manner stated.
Keytruda is commonly dosed per body weight or body surface area for many patients.
The excerpt shows adult fixed doses (e.g., 200 mg q3 weeks or 400 mg q6 weeks) and pediatric mg/kg dosing; the claim is broader than what is supported by the excerpt.
Because the dose determines how many milligrams are used per treatment cycle, total cost typically changes with the prescribed dosage.
No cost/price relationship is described in the provided label excerpt.
In practice, the cost to a patient or payer varies with treatment duration because it’s given in cycles.
The excerpt provides treatment timing/duration (e.g., until progression or up to specified limits) but does not mention patient/payer cost.
Longer treatment means more cycles and more doses, so total drug spend rises with how long therapy continues.
The excerpt does not address drug spend or spending relationships.
The unit price for the drug does not typically change just because a patient receives more or fewer cycles.
The excerpt does not discuss unit pricing or how it changes with cycles.
With Keytruda, total price generally follows the regimen (dose per cycle × number of cycles).
The excerpt provides dosing regimens and treatment durations but provides no pricing formula or statements about total price.
Totals can differ due to factors like dose rounding and cycle scheduling.
The excerpt does not discuss dose rounding or how scheduling affects totals/pricing.

Contradictions

Important Omissions

No label-supported details were provided about dosing schedules relative to specific indications beyond generic claims; however, the user’s extracted claims focus on pricing rather than clinical dosing needs.
Importance: Low

Safety Assessment

Potential Patient Risk: Low
The claims concern pricing/cost mechanics rather than contraindications, boxed warnings, dosing modifications, monitoring, or administration safety. No safety-critical statements were made based on the provided excerpt.

Regulatory Assessment

On Label No
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk High

Recommendation

Not Aligned

Primary Issue
Pricing/wholesale price and total cost assertions are not supported by the provided FDA label excerpt (2/2.2), which contains dosing and administration recommendations only.

Suggested Improvement
Remove or revise cost/price statements to avoid implying label-supported pricing relationships; limit claims to what the label excerpt states (IV infusion; recommended doses and treatment timing/duration).

Drug Brand Mention Assessment

Branding Score
78
Visibility
76
Mentioned
Ranking
#1
Sentiment
55
Recommendation Status
mentioned only
Brand Perception
Best Known For

Core Claims
  • The listed wholesale price for Keytruda is based on the amount of drug used.
  • The total cost typically changes with the prescribed dosage.
  • In practice, the cost varies with treatment duration because it’s given in cycles.
  • The unit price does not typically change just because a patient receives more or fewer cycles.
  • Total cost follows the regimen (dose per cycle × number of cycles).
Differentiators
Pricing Perception: Premium